James McCullough
Founder bei RENALYTIX PLC
Vermögen: 1 Mio $ am 31.03.2024
Aktive Positionen von James McCullough
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RENALYTIX PLC | Director/Board Member | 15.03.2018 | - |
| Chief Executive Officer | 15.03.2018 | - | |
| Founder | 15.03.2018 | - | |
| VERICI DX PLC | Director/Board Member | 22.04.2020 | - |
| LUNGLIFE AI, INC. | Director/Board Member | 01.01.2019 | - |
| Independent Dir/Board Member | 01.01.2019 | - | |
Renwick Capital LLC
 Renwick Capital LLC Investment ManagersFinance Renwick Capital LLC provides investment services. | Corporate Officer/Principal | 01.01.2014 | - |
BalletNext, Inc.
 BalletNext, Inc. Internet Software/ServicesTechnology Services BalletNext, Inc. is a dance-driven platform that creates dynamic international collaborations between world-class artists, emerging talent, and renowned institutions. The non-profit company is based in Park City, UT and is a 501 (c) 3 nonprofit organization, made possible by grants and contributions from generous individuals. BalletNext produces boundary-crossing performance projects and one-of-a-kind, immersive training opportunities. The company was founded in 2011 by Michele Wiles, a former principal dancer with American Ballet Theatre. | Chairman | - | - |
| The Bonnie J. Addario Lung Cancer Foundation | Director/Board Member | - | - |
Kantaro Biosciences LLC
 Kantaro Biosciences LLC Medical SpecialtiesHealth Technology Kantaro Biosciences LLC is a health system venture that provides high-quality diagnostic tests for critical health challenges. The joint venture company is based in New York, NY. The company is dedicated to advancing the care and well-being of people, communities, and society by offering rigorous, results-driven, and reproducible diagnostics. Kantaro specializes in the rapid scale-up of groundbreaking diagnostic innovations and the creation of partnerships to bring these crucial technologies to market. | Director/Board Member | - | - |
| Renalytix AI, Inc. | Director/Board Member | - | - |
| Go2 Foundation For Lung Cancer | Director/Board Member | - | - |
Karriereverlauf von James McCullough
Ehemalige bekannte Positionen von James McCullough
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░ | - | - |
Ausbildung von James McCullough
| Boston University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 16 |
| Israel | 2 |
Operativ
| Director/Board Member | 10 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sektoral
| Health Services | 4 |
| Commercial Services | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| LUNGLIFE AI, INC. | Health Services |
| RENALYTIX PLC | Technology Services |
| VERICI DX PLC | Health Services |
| Private Unternehmen | 11 |
|---|---|
Quentra Networks, Inc.
 Quentra Networks, Inc. Specialty TelecommunicationsCommunications Quentra Networks, Inc. sells wholesale long distance services primarily to entrepreneurial carriers and it markets retail international long distance services primarily to affinity groups. The company was founded in 1961 and is headquartered in Los Angeles, CA. | Communications |
Ausam Biotechnologies, Inc.
 Ausam Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Ausam Biotechnologies, Inc. provides biophysics and physiology research and development services. | Commercial Services |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Health Services |
| The Bonnie J. Addario Lung Cancer Foundation | Commercial Services |
Paige.Ai, Inc.
 Paige.Ai, Inc. Miscellaneous Commercial ServicesCommercial Services Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY. | Commercial Services |
TAVEC Pharmaceuticals
 TAVEC Pharmaceuticals Pharmaceuticals: MajorHealth Technology TAVEC Pharmaceuticals develops novel drugs pharm. The company was founded by Fred Hochberg and is headquartered in New York, NY. | Health Technology |
Renwick Capital LLC
Renwick Capital LLC Investment ManagersFinance Renwick Capital LLC provides investment services. | Finance |
BalletNext, Inc.
BalletNext, Inc. Internet Software/ServicesTechnology Services BalletNext, Inc. is a dance-driven platform that creates dynamic international collaborations between world-class artists, emerging talent, and renowned institutions. The non-profit company is based in Park City, UT and is a 501 (c) 3 nonprofit organization, made possible by grants and contributions from generous individuals. BalletNext produces boundary-crossing performance projects and one-of-a-kind, immersive training opportunities. The company was founded in 2011 by Michele Wiles, a former principal dancer with American Ballet Theatre. | Technology Services |
Kantaro Biosciences LLC
Kantaro Biosciences LLC Medical SpecialtiesHealth Technology Kantaro Biosciences LLC is a health system venture that provides high-quality diagnostic tests for critical health challenges. The joint venture company is based in New York, NY. The company is dedicated to advancing the care and well-being of people, communities, and society by offering rigorous, results-driven, and reproducible diagnostics. Kantaro specializes in the rapid scale-up of groundbreaking diagnostic innovations and the creation of partnerships to bring these crucial technologies to market. | Health Technology |
| Renalytix AI, Inc. | |
| Go2 Foundation For Lung Cancer |
- Börse
- Insiders
- James McCullough
- Erfahrung
